Novel bioadhesive drug delivery system protecting (poly)peptides from gastric enzymatic degradation

International Journal of Pharmaceutics

Volumn 138, Issue 1, 1996, Pages 75-83

  Bernkop Schnurch A ^a   Dundalek, K ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bioadhesive drug delivery system; Epidermal growth factor; Gastric ulcers; Pepsin; pepstatin; Sodium carboxymethyl cellulose

Indexed keywords

BOVINE INSULIN; CARBOXYMETHYLCELLULOSE; DRUG CARRIER; EPIDERMAL GROWTH FACTOR; HORSERADISH PEROXIDASE; PEPSTATIN;

ARTICLE; DRUG CONJUGATION; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENZYME ACTIVITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; STOMACH ULCER;

EID: 0030581134     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)04532-2     Document Type: Article

References (22)

1. Achleitner, B., Bioadhäsive Arzneiformulierungen: Freisetzung, Stabilität und Dotierung mit Fimbrien. Thesis, University of Vienna, Austria, 1995.
2. Bernkop-Schnürch, A., Gabor, F., Szostak, M.P. and Lubitz, W., An adhesive drug delivery system based on K99-fimbriac. Eur. J. Pharm. Sci., 3 (1995) 293-299.
3. Carmel, R., In vitro studies of gastric juice in patients with food-cobalamin malabsorption. Dig. Dis. Sci., 39 (1994) 2516-2522.
4. Cho, Y.-K., Rebholz, K.L. and Northrop, D.B., Solvent isotope effects on the onset of inhibition of porcine pepsin by pepstatin. Biochemistry, 33 (1994) 9637-9642.
5. Ch'ng, H.S., Park, H., Kelly, P. and Robinson, R., Bioadhesive polymers as platforms for oral controlled drug delivery II: synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers. J. Pharm. Sci., 74 (1985) 399-405.
6. Copeman, M., Matuz, J., Leonard, A.J., Pearson, J.P., Dettmar, P.W. and Allen, A., The gastroduodenal mucus barrier and its role in protection against luminal pepsins - the effect of 16,16 dimethyl prostaglandin E(2), carbopol-polyacrylate, sucralfate and bismuth subsalicylate. J. Gastroenterol. Hepatol., 9 (1994) S55-S59.
7. Goodfriend, T.L., Levine, L. and Fasman, G.D., Antibodies to bradykinin and angiotensin: a use of carbodiimides in immunology. Science, 144 (1966) 1344-1346.
8. Harms, E. and Bertele-Harms, R.M., Der Mukoviszidosepatient im Übergang vom Kindes-zum Erwachsenenalter. Internist, 35 (1994) 239-249.
9. Hollenberg, M.D., Epidermal growth factor-urogastrone, a polypeptide acquiring hormonal status. Vitam. Horm., 37 (1979) 69-110.
10. Itoh, M. and Matsuo, Y., Gastric ulcer treatment with intravenous human epidermal growth factor: a double-blind controlled clinical study. J. Gastroenterol. Hepatol., 9 (1994) S78-S83.
11. Junginger, H.E. and Lehr, C.-M., Bioadhäsive Arzneistoffabgabesysteme und Arzneiformen für perorale und rektale Anwendung. Dtsch. Apoth. Zig., 130 (1990) 791-801.
12. Konturec, S.J., Brzozowski, T. and Piastucki, I., Role of mucosal prostaglandines and DNA synthesis in gastric cytoprotection by luminal epidermal growth factor. Gut, 22 (1981) 927-932.
13. McCaffrey, G. and Jamieson, J.C., Evidence for the role of a cathepsin D-like activity in the release of gal β 1-4 glcnac α 2-6 sialyltransferase from rat and mouse liver in whole-cell systems. Comp. Biochem. Phys. C., 104 (1993) 91-94.
14. McConnell, R.M., Frizzell, D., Evans, A.C.A., Jones, W. and Cagle, C., New pepstatin analogues: synthesis and pepsin inhibition. J. Med. Chem., 34 (1991) 2298-2300.
15. Meyer, B.R., Kreis, W. and Eschbach, J., Transdermal versus subcutaneous leuprolide: a comparison of acute pharmacodynamic effect. Clin. Pharmacol. Ther., 48 (1990) 340-345.
16. Plumpton, C., Kalinka, S., Martin, R.C., Horton, J.K. and Davenport, A.P., Effects of phosphoramidon and pepstatin A on the secretion of endothelin-1 and big endothelin-1 by human umbilical vein endothelial cells - measurement by two-site enzyme-linked immunosorbent assays. Clin. Sci., 87 (1994) 245-251.
17. Poulsen, S.S., Skov, O.P. and Kirkegaard, P., Healing of cysteamine-induced duodenal ulcers in the rat. Dig. Dis. Sci., 30 (1985) 161-167.
18. Sangaletti, O., Petrillo, M., Santalucia, F., Zhu, H., Trape, E. and Porro, G.B., Effect of mucoactive mucolytic drugs on the integrity of the gastric mucosal barrier - a preliminary comparison between S-Carboxymethylcysteine Lysine salt and N-Acetylcysteine. Curr. Ther. Res. Clin. Exp., 55 (1994) 480-486.
19. Skov, O.P., Poulsen, S.S., Kirkegaard, P. and Nexo, E., Role of submandibular saliva and epidermal growth factor in gastric cytoprotection. Gastroenterology, 87 (1984) 103-108.
20. Slomiany, B.L., Nishikawa, H., Bilski, J. and Slomiany, A., Colloidal bismuth subcitrate inhibits peptic degradation of gastric mucus and epidermal growth factor in vitro. Am. J. Gastroenterol., 85 (1990) 390-393.
21. Staros, J.V., Wright, R.W. and Swingle, D.M., Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions. Anal. Biochem., 156 (1986) 220-222.
22. Valkonen, K.H., Wadstrom, T. and Moran, A.P., Interaction of lipopolysaccharides of Helicobacter pylori with basement membrane protein laminin. Infect. Immun., 62 (1994) 3640-3648.